Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Brenipatide in Pulmonary Disease, Chronic Obstructive: NCT07759245 Clinical Landscape Report 2026
16 September 2026
NCT07759245 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development whit…
9 min read
Durvalumab in Non-small cell lung cancer stage III: NCT07759492 Clinical Landscape Report 2026
16 September 2026
NCT07759492 clinical landscape for Non-small cell lung cancer stage III: endpoints, sponsor, phase, geography, readouts, asset context and development white…
9 min read
Heparin Calcium in Kidney Failure, Chronic: NCT07759167 Clinical Landscape Report 2026
16 September 2026
NCT07759167 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
VY-1706 in Alzheimer Disease: NCT07764146 Clinical Landscape Report 2026
16 September 2026
NCT07764146 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BL-ARC002 in Esophageal Squamous Cell Carcinoma: NCT07763652 Clinical Landscape Report 2026
16 September 2026
NCT07763652 clinical landscape for Esophageal Squamous Cell Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Golcadomide Hydrochloride in Kidney Failure, Chronic: NCT07763418 Clinical Landscape Report 2026
16 September 2026
NCT07763418 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
YMN-136 Vaccine in Liver Cancer: NCT07763301 Clinical Landscape Report 2026
16 September 2026
NCT07763301 clinical landscape for Liver Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Albumin-Bound Paclitaxel in Metastatic Carcinoma to the Uterine Cervix: NCT07763496 Clinical Landscape Report 2026
16 September 2026
NCT07763496 clinical landscape for Metastatic Carcinoma to the Uterine Cervix: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
Tislelizumab in PD-L1 positive Gastroesophageal junction adenocarcinoma: NCT07763171 Clinical Landscape Report 2026
16 September 2026
NCT07763171 clinical landscape for PD-L1 positive Gastroesophageal junction adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and…
9 min read
64Cu-RAX301 in Oligometastatic Prostate Carcinoma: NCT07765940 Clinical Landscape Report 2026
16 September 2026
NCT07765940 clinical landscape for Oligometastatic Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white sp…
9 min read
Safinamide mesylate in Young onset Parkinson disease: NCT07761936 Clinical Landscape Report 2026
16 September 2026
NCT07761936 clinical landscape for Young onset Parkinson disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Sodium Bicarbonate in Vascular Calcification: NCT07765459 Clinical Landscape Report 2026
16 September 2026
NCT07765459 clinical landscape for Vascular Calcification: endpoints, sponsor, phase, geography, readouts, asset context and development white space.